Neutralizing and non-neutralizing antibody responses in HIV-1 subtype C chronically infected patients with divergent rates of disease progression 由 Archary, D, Rong, R, Gordon, M, Boliar, S, Gray, E, Dugast, A, Hermanus, T, Goulder, P, Coovadia, H, Morris, L, Alter, G, Derdeyn, C, Ndung'u, T

Characterization of anti-HIV-1 neutralizing and binding antibodies in chronic HIV-1 subtype C infection. 由 Archary, D, Rong, R, Gordon, M, Boliar, S, Madiga, M, Gray, E, Dugast, A, Hermanus, T, Goulder, P, Coovadia, H, Werner, L, Morris, L, Alter, G, Derdeyn, C, Ndung'u, T

Characterization of anti-HIV-1 neutralizing and binding antibodies in chronic HIV-1 subtype C infection 由 Archary, D, Rong, R, Gordon, M, Boliar, S, Madiga, M, Gray, E, Dugast, A, Hermanus, T, Goulder, P, Coovadia, H, Werner, L, Morris, L, Alter, G, Derdeyn, C, Ndung'u, T

Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activity 由 Ackerman, M, Crispin, M, Yu, X, Baruah, K, Boesch, A, Harvey, D, Dugast, A, Heizen, E, Ercan, A, Choi, I, Streeck, H, Nigrovic, P, Bailey-Kellogg, C, Scanlan, C, Alter, G